Headway on AIDS threatened by funding slowdown
PROGRESS in beating back the AIDS epidemic risks being eroded by a funding shortfall set to grow under Donald Trump’s proposed cuts to global health projects, experts and campaigners warned ahead of a major HIV conference.
If adopted by Congress, the 2018 Trump budget could deprive some 830,000 people, mostly in Africa, from life-saving anti-AIDS drugs, according to calculations by the Kaiser Family Foundation, a California-based health policy NGO.
“We will see lives needlessly being lost,” said Linda-Gail Bekker, president of the International AIDS Society, which is hosting some 6,000 experts in Paris from yesterday to take stock of advances in HIV science. “We’re not talking about maybe a slowing down . . . if these [US] cuts come about we could very well see a real turnaround in terms of the progress that has been made.”
A Trump budget could lead to nearly 200,000 new HIV infections, according to the KFF. It could also leave as many as 25 million couples without access to sponsored contraceptives, which not only prevent pregnancy but also virus spread.
“I cannot tell you how anxious I feel . . . To have the funding carpet taken from under our feet just seems such an incredible travesty,” said Bekker.
The United States has for years been the biggest contributor to the global fight against HIV infection, accounting for about two-thirds of funding by governments.
Last year, it contributed $4.9 billion to global HIV projects – 7.5 times the amount provided by second-placed donor Britain.
Trump’s proposed budget, submitted in May, would reduce this amount by about $1 billion, according to Health Global Access Project, an activist group which crunched the numbers.
The US president put forward a blueprint which, in its own words, “reduces funding for several global health programmes, including HIV/AIDS, with the expectation that other donors can and should increase their commitments.”
The draft spending plan proposes to “maintain current commitments and all current patient levels on HIV/AIDS treatment” under the President’s Emergency Plan for AIDS Relief, or Pepfar, set up by George W. Bush in 2003.
The programme provides anti-retroviral treatment to over 12 million people.
The goal of Pepfar, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, a US government research agency, “is to get more people who have been newly infected on therapy” – which means more money.
“If you don’t increase it, you . . . have more responsibilities that you are not able to meet.”
Since the epidemic erupted in the 1980s, 76.1 million people have been infected with HIV, the virus that causes AIDS. Some 35 million have died. Last year, AIDS killed a million people and infected another 1.8 million, according to the UN.
And while infections and deaths are on the decline, the number of people living with HIV – requiring lifelong treatment – continues to grow.
Last year, 19.5 million of the 36.7 million people who needed it, had access to ART.
By 2020, the UN is aiming for 90 percent of HIV-infected people to be on medication. But to achieve this target, annual spending must reach $26.2 billion, according to UNAIDS.